Program at a Glance
The schedule is tentative and subject to change. |
June 21 (Thursday) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Location | Crystal Ballroom (2F) | Pine Room | Sapphire Ballroom (3F) | Belle-vue Suite | Emerald Room | ||||
Room | Room A | Room B | Room C | (3F) | Room A | Room B | Room C | (36F) | (2F) |
08:00-09:00 | Registration | ||||||||
09:00-10:40 | ES-1 [KOR] | ES-2 [KOR] | SP-01 [ENG] | SP-02 [ENG] | YIS [KOR] | MC-1 [ENG] |
Poster Presentation 1 (09:00-17:00)
|
||
Foundation of precision oncology | Progress in surgical treatment for malignant disease | Emerging molecular segments in gastrointestinal cancer | Clinical trials and molecular imaging biomarkers | Young Investigator Symposium | Time-traveling in the IO space:
Investigate the current status and foresight the IO space |
||||
10:40-11:00 | Coffee Break | ||||||||
11:00-11:30 | [ENG] Plenary Lecture 1 - Prof. Ho-Young Lee | ||||||||
11:30-12:20 | [ENG] Plenary Lecture 2 - Dr. Peter Campbell | ||||||||
12:20-13:20 | SS-01 [ENG] - MSD | SS-02 [ENG] - ONO/BMS | SS-03 [ENG] - Novartis | ||||||
The art of immuno-therapy in NSCLC | Emerging horizons in gastric cancer immun-otherapy | Ceritinib: How to optimize treatment of ALK + NSCLC in 1L | |||||||
13:20-15:00 | SP-03 [ENG] | SP-04 [ENG] | SP-05 [KOR] | SP-06 [ENG] | ES-3 [KOR] | SP-07 [ENG] | SP-08 [ENG] | MC-2 [ENG] | |
Plasma genotyping for precision medicine | Change of surgical strategy by multi-
disciplinary treatment |
Key issues in biosimilars | Multifocal lung cancer: The same or different? Aggressive or conservative? | Genomic and immuno-oncology era in radiation oncology | Recent progress in cancer epigenomics | Micro-environment and tumorigenesis 1 | Evaluating current and emerging strategies using checkpoint inhibitors: Where are we now and where are we going? | ||
15:00-15:20 | Coffee Break | ||||||||
15:20-17:00 | SP-09 [ENG] | SP-10 [KOR] | SP-11 [ENG] | SP-12 [ENG] | SP-13 [ENG] | SP-14 [ENG] | MC-3 [ENG] | ||
Personalized cancer immuno-
therapy |
Hospice and palliative care | Genomic alterations in premalignant lesions | Bio-medical research using big accelerators | Optimization of adjuvant systemic treatment for EBC | Micro-environment and tumorigenesis 2 | Towards personalised healthcare: Overcoming the challenges of NGS-based cancer profiling | |||
17:00-18:00 | IS-01 [ENG] | IS-02 [ENG] | IS-03 [ENG] | IS-04 [ENG] | IS-05 [ENG] | OP-1 [KOR] | OP-2 [KOR] | ||
Basic research 1 | Basic research 2 | Lung and H&N cancer | GI cancer 1 (HBP, Colorectal) | Radiation oncology | Basic research (Colorectal cancer) | Supportive care, pediatric cancer and radiation oncology |
6/21 Session Remarks | SP-03 | Joint Symposium (Korean Cancer Association & Korean Society for Laboratory Medicine) | |||||||
---|---|---|---|---|---|---|---|---|---|
SP-08, 14 | Joint Symposia (Korean Cancer Association & Shanghai Cancer Institute) | ||||||||
SP-11 | Joint Symposium (Korean Cancer Association & The Korean Society of Pathologists) | ||||||||
SP-12 | Joint Symposium (Korean Cancer Association & the Center for Korean Users of Heavy-Ion Facilities) | ||||||||
ES Educational Session | YIS Young Investigator Symposium | PL Plenary Lecture |
MC Master Class | SP Symposium | OAS Outstanding Abstract Session |
SS Satellite Symposium | OP Oral Presentation | IS International Session (Oral) |
June 22 (Friday) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Location | Crystal Ballroom (2F) | Pine Room | Sapphire Ballroom (3F) | Belle-vue Suite | Emerald Room | ||||
Room | Room A | Room B | Room C | (3F) | Room A | Room B | Room C | (36F) | (2F) |
08:00-09:00 | Registration | ||||||||
09:00-10:00 | [ENG] Outstanding Abstract Session | IS-06 [ENG] | OP-3 [KOR] | OP-4 [KOR] | IS-07 [ENG] |
Poster Presentation 2 (09:00-17:00)
|
|||
Basic research 3 | H&N and other cancers | Colorectal cancer | Lung cancer | ||||||
10:00-10:20 | Coffee Break | ||||||||
10:20-10:50 | [ENG] Plenary Lecture 3 - Prof. Dong-Young Noh | ||||||||
10:50-11:40 | [ENG] Plenary Lecture 4 - Prof. Frank McCormick | ||||||||
11:50-12:50 | SS-04 [ENG] - Roche | SS-05 [ENG] - Lilly | SS-06 [ENG] - Pfizer | ||||||
Harnessing the power of immunotherapy and targeted therapy in lung cancer | Current status and real world experience of anti-angiogenesis in Advanced Gastric Cancer | Reassuring the absolute survival benefit of ALK sequential therapy and the value of First-in-class ROS1 inhibitor | |||||||
12:50-13:20 | KCA General Assembly | Special Lecture |
|||||||
Dr. Anindya Dutta | |||||||||
13:20-13:40 | Break | ||||||||
13:40-15:20 | SP-15 [KOR] | IS-08 [ENG] | SP-16 [ENG] | IS-09 [ENG] | SP-17 [ENG] | SP-18 [ENG] | SP-19 [ENG] | MC-4 [ENG] | |
Gynecologic Cancer | |||||||||
Promising anti-cancer drug pipeline in pre-clinical and clinical stages in Korea | OP-5 [KOR] | Tailored care for young women with cancer | GI cancer 2 (Esophagus, stomach, CRC) | Recent updates and future perspectives on the hepato-biliary cancer | Current debate in the oncologic management of rectal cancer | Multi-omics approaches in cancer research | A forum on tumor microenvironment | ||
Breast and gynecologic cancer | |||||||||
15:20-15:40 | Coffee Break | ||||||||
15:40-17:20 | SP-20 [KOR] | SP-21 [ENG] | SP-22 [ENG] | IS-10 [ENG] | IS-11 [ENG] | SP-23 [ENG] | IS-12 [ENG] | ||
Genitourinary Cancer | |||||||||
From scientific lead to companion diagnostics (CDx) approval process in Korea | Multi-
disciplinary care of BRCA mutation carriers |
Update of gastric cancer research in Korea | Basic research 4 | Head and neck cancer | Tumor immunity and immuno-therapy | OP-6 [KOR] | |||
Genitourinary Cancer | |||||||||
17:30-19:00 | Closing Reception @ Belle-vue Suite (36F) |
6/22 Session Remarks | SP-15 | National OncoVenture Symposium | |||||||
---|---|---|---|---|---|---|---|---|---|
SP-19 | Joint Symposium (Korean Cancer Association & Korea Genome Organization) | ||||||||
SP-21 | Joint Symposium (Korean Cancer Association & Korean Society of Gynecologic Oncology) | ||||||||
SP-23 | Joint Symposium (Korean Cancer Association & Beijing Medical Association) |
ES Educational Session | YIS Young Investigator Symposium | PL Plenary Lecture |
MC Master Class | SP Symposium | OAS Outstanding Abstract Session |
SS Satellite Symposium | OP Oral Presentation | IS International Session (Oral) |